Image credits: PeakData
Switzerland-based PeakData, an AI platform that helps pharmaceutical companies learn more about their customers, announced on Monday that it has secured €12.1M in a Series A round of funding. The round was led by AlbionVC, with participation from Octopus Ventures and Heal Capital.
According to the company, Series A funding round follows rapid 6x growth for the company in 2021.
The Zug-based company says it will use the funds to accelerate its growth and platform development.
Patrick De Boer, co-founder of PeakData, says, “We started PeakData after a dawning realisation that AI could help provide better patient outcomes. To ensure healthcare professionals are aware of the latest medicines, pharmaceutical companies must be provided with the latest data about them and their key focus areas. We see PeakData as filling a key gap in how our customers receive and analyse this data to improve the conversations they are having with a much wider variety of HCPs in their area. Combining our AI approach and platform with the global presence of several pharmaceutical companies will have an immediate and long-term positive impact on our customers and the patients they serve. We’re delighted that Albion shares this vision and look forward to working with them in the future.”
Peakdata: What you need to know
Founded by data scientists Patrick De Boer and Michael Feldman in 2018, PeakData enables pharmaceutical companies to enhance the depth and breadth of their customer base and learn more about HCPs (Healthcare Professionals) that are most relevant to their target market.
The company uses AI algorithms to crawl through millions of digital records to rank HCPs regarding their digital impact, influence, and relevance to their target market. It also uses dynamic data to observe changes in HCP status over time.
As a result, pharma companies can find and personalise their communications with top-tier experts as the market changes.
Similarly, new and emerging influencers are much more easily uncovered with PeakData, as the platform gives users constant insights on digital activators – a practising HCP with a robust and established digital presence and actively shapes clinical opinion.
The Swiss company provides support to pharma companies throughout the lifecycle of their medicine, from giving them greater insight into their target market ahead of a medicine’s launch to boosting the medicine’s growth through insights and information on a much larger potential customer base.
PeakData’s platform is fully customisable and can be tailored according to the customers – from onboarding and training to support rapid deployment across a business.
PeakData has offices in 5 countries and services more than 20 large pharma clients globally.
Investor
AlbionVC supports visionary founders with long-term capital and scale-up expertise. The company manages $1B of venture funds invested in over 50 companies.
Christoph Ruedig, partner at AlbionVC, says, “When we first met Patrick, Michael, and the team, we were impressed by their dedication, drive, and determination to develop the best data AI platform in a healthcare setting. Finding the right therapeutic experts and healthcare professionals for their medicines is massively important for pharmaceutical companies. With PeakData, they can now reach global, national, and local medical professionals who shape clinical decision-making. The potential for PeakData to help provide better patient outcomes and improve the decision-making of key healthcare professionals is very exciting, and we’re pleased to join the team on this journey.”
Catch our interview with Paul Down, Head of Sales at Intigriti.
![Read more about the article [Funding alert] CpaaS company CometChat raises $10M in Series A round](https://blog.digitalsevaa.com/wp-content/uploads/2021/12/cometchat-1638863383406-300x150.png)
